|
⚲
|
| Keyboard |
| Louis Roger
✚
|
|
|---|---|
| CIK # | 0001659747 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001659747] | |
| 4 | [0001659747] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Novelion Therapeutics Inc | |
| Louis Roger | |
| Aegerion Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Novelion Therapeutics Inc NVLN
Common Stock
|
2019-05-09 | Tax withheld | 155 | $1.22 | 189 |
|
Novelion Therapeutics Inc NVLN
Common Stock
|
2018-05-09 | Tax withheld | 161 | $4.26 | 686 |
|
Novelion Therapeutics Inc NVLN
Stock Option (Right to Buy) · derivative
|
2018-02-12 | Grant | 25,000 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Common Shares
|
2017-05-09 | Tax withheld | 162 | $9.42 | 1,526 |
|
Novelion Therapeutics Inc NVLN
Restricted Stock Units · derivative
|
2017-05-09 | Option exercise | 547 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Common Shares
|
2017-05-09 | Option exercise | 547 | ||
|
Novelion Therapeutics Inc NVLN
Stock Option (right to buy) · derivative
|
2016-12-22 | Grant | 41,740 | $0.00 | |
|
Aegerion Pharmaceuticals Inc AEGR
Stock Option (Right to Buy) · derivative
|
2016-11-29 | Disposed to issuer | 85,000 | ||
|
Novelion Therapeutics Inc NVLN
Restricted Stock Units · derivative
|
2016-11-29 | Grant | 8,204 | ||
|
Aegerion Pharmaceuticals Inc AEGR
Restricted Stock Units · derivative
|
2016-11-29 | Disposed to issuer | 8,000 | ||
|
Aegerion Pharmaceuticals Inc AEGR
Stock Option (Right to Buy) · derivative
|
2016-11-29 | Disposed to issuer | 17,000 | ||
|
Aegerion Pharmaceuticals Inc AEGR
Stock Option (right to buy) · derivative
|
2016-05-09 | Grant | 17,000 | $0.00 | |
|
Aegerion Pharmaceuticals Inc AEGR
Restricted Stock Units · derivative
|
2016-05-09 | Grant | 8,000 | $0.00 | |
|
Aegerion Pharmaceuticals Inc AEGR
Stock Option (right to buy) · derivative
|
2015-12-01 | Grant | 85,000 | $0.00 |